本页面由Tiger Trade Technology Pte. Ltd.提供服务

CALCIMEDICA

0.8178
-0.1122-12.06%
盘后0.8044-0.0134-1.64%19:53 EDT
成交量:57.53万
成交额:49.67万
市值:1,291.96万
市盈率:-0.64
高:0.9247
开:0.9100
低:0.8001
收:0.9300
52周最高:7.20
52周最低:0.4606
股本:1,579.80万
流通股本:99.06万
量比:1.77
换手率:58.08%
股息:- -
股息率:- -
每股收益(TTM):-1.2684
每股收益(LYR):-1.9700
净资产收益率:-399.51%
总资产收益率:-81.85%
市净率:-11.70
市盈率(LYR):-0.42

数据加载中...

公司资料

公司名字:
CALCIMEDICA
交易所:
NASDAQ
成立时间:
- -
员工人数:
16
公司地址:
505 Coast Boulevard South,Suite 307,La Jolla,California,United States
邮编:
92037
电话:
传真:
- -
简介:
CalciMedica, Inc.于2015年2月根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。公司候选产品作用于钙释放活化钙(“CRAC”)通道,将构成一类新药。

董事

名称
职位
A. Rachel Leheny
Chief Executive Officer and Director
Alan Glicklich
Independent Director
Allan Shaw
Independent Director
Eric W. Roberts
Chief Business Officer and Director
Fred Middleton
Independent Director
Frederic Guerard
Independent Director
Robert N. Wilson
Independent Director

股东

名称
职位
A. Rachel Leheny
Chief Executive Officer and Director
Michael J. Dunn
Chief Operating Officer and President
Stephen Bardin
Chief Financial Officer
Eric W. Roberts
Chief Business Officer and Director
Kenneth A. Stauderman
Chief Scientific Officer
Sudarshan Hebbar
Chief Medical Officer